[1]
S. Sansone, Y. Amir, and M. Lebwohl, “Safe use of Interleukin-17 Inhibitors for Psoriasis and Psoriatic Arthritis in Two Patients with a History of Lymphoproliferative Disease”, J of Skin, vol. 4, no. 3, pp. 256-259, May 2020.